Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Antiinflammatory bone resorption inhibitors from Takeda

July 12, 1996

Bayer discloses matrix metalloproteinase inhibitors

July 12, 1996

COX-2 inhibitors for inflammation and/or pain from Roche

July 12, 1996

Novel antibacterial agents from Pharmacia & Upjohn

July 12, 1996

Erythromycin derivatives useful for infection treatment

July 12, 1996

Lilly describes heterocyclic tachykinin antagonists

July 12, 1996

Sandoz reports new NMDA antagonist

July 5, 1996

Nippon Chemiphar reports oral hypoglycemic agents for diabetes

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...